Literature DB >> 23139223

D-Glucose modulates intestinal Niemann-Pick C1-like 1 (NPC1L1) gene expression via transcriptional regulation.

Pooja Malhotra1, Craig S Boddy, Vinay Soni, Seema Saksena, Pradeep K Dudeja, Ravinder K Gill, Waddah A Alrefai.   

Abstract

The expression of intestinal Niemann-Pick C1-like 1 (NPC1L1) cholesterol transporter has been shown to be elevated in patients with diseases associated with hypercholesterolemia such as diabetes mellitus. High levels of glucose were shown to directly increase the expression of NPC1L1 in intestinal epithelial cells, but the underlying mechanisms are not fully defined. The present studies were, therefore, undertaken to examine the transcriptional regulation of NPC1L1 expression in human intestinal Caco2 cells in response to glucose. Removal of glucose from the culture medium of Caco2 cells for 24 h significantly decreased the NPC1L1 mRNA, protein expression, as well as the promoter activity. Glucose replenishment significantly increased the promoter activity of NPC1L1 in a dose-dependent manner compared with control cells. Exposure of Caco2 cells to nonmetabolizable form of glucose, 3-O-methyl-d-glucopyranose (OMG) had no effect on NPC1L1 promoter activity, indicating that the observed effects are dependent on glucose metabolism. Furthermore, glucose-mediated increase in promoter activity was abrogated in the presence of okadaic acid, suggesting the involvement of protein phosphatases. Glucose effects on several deletion constructs of NPC1L1 promoter demonstrated that cis elements mediating the effects of glucose are located in the region between -291 and +56 of NPC1L1 promoter. Consistent with the effects of glucose removal on NPC1L1 expression in Caco2 cells, 24-h fasting resulted in a significant decrease in the relative expression of NPC1L1 in mouse jejunum. In conclusion, glucose appears to directly modulate NPC1L1 expression via transcriptional mechanisms and the involvement of phosphatase-dependent pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23139223      PMCID: PMC3543648          DOI: 10.1152/ajpgi.00288.2012

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  28 in total

1.  Modulation of intestinal cholesterol absorption by high glucose levels: impact on cholesterol transporters, regulatory enzymes, and transcription factors.

Authors:  Z Ravid; M Bendayan; E Delvin; A T Sane; M Elchebly; J Lafond; M Lambert; G Mailhot; E Levy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-09-04       Impact factor: 4.052

Review 2.  Bile acid transporters: structure, function, regulation and pathophysiological implications.

Authors:  Waddah A Alrefai; Ravinder K Gill
Journal:  Pharm Res       Date:  2007-04-03       Impact factor: 4.200

3.  HNF1alpha and SREBP2 are important regulators of NPC1L1 in human liver.

Authors:  Camilla Pramfalk; Zhao-Yan Jiang; Qu Cai; Hai Hu; Sheng-Dao Zhang; Tian-Quan Han; Mats Eriksson; Paolo Parini
Journal:  J Lipid Res       Date:  2010-06       Impact factor: 5.922

4.  Modulation of human Niemann-Pick C1-like 1 gene expression by sterol: Role of sterol regulatory element binding protein 2.

Authors:  Waddah A Alrefai; Fadi Annaba; Zaheer Sarwar; Alka Dwivedi; Seema Saksena; Amika Singla; Pradeep K Dudeja; Ravinder K Gill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2006-09-28       Impact factor: 4.052

5.  Genes that affect cholesterol synthesis, cholesterol absorption, and chylomicron assembly: the relationship between the liver and intestine in control and streptozotosin diabetic rats.

Authors:  Sean Lally; Daphne Owens; Gerald H Tomkin
Journal:  Metabolism       Date:  2007-03       Impact factor: 8.694

Review 6.  Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.

Authors:  Lin Jia; Jenna L Betters; Liqing Yu
Journal:  Annu Rev Physiol       Date:  2011       Impact factor: 19.318

7.  ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver.

Authors:  Pierre-Damien Denechaud; Pascale Bossard; Jean-Marc A Lobaccaro; Lesley Millatt; Bart Staels; Jean Girard; Catherine Postic
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

Review 8.  The intestine as a regulator of cholesterol homeostasis in diabetes.

Authors:  Gerald H Tomkin
Journal:  Atheroscler Suppl       Date:  2008-08-06       Impact factor: 3.235

Review 9.  ChREBP: a glucose-activated transcription factor involved in the development of metabolic syndrome.

Authors:  Katsumi Iizuka; Yukio Horikawa
Journal:  Endocr J       Date:  2008-05-19       Impact factor: 2.349

Review 10.  Glucose regulation of insulin gene expression in pancreatic beta-cells.

Authors:  Sreenath S Andrali; Megan L Sampley; Nathan L Vanderford; Sabire Ozcan
Journal:  Biochem J       Date:  2008-10-01       Impact factor: 3.857

View more
  12 in total

Review 1.  Dyslipidaemia of diabetes and the intestine.

Authors:  Gerald H Tomkin; Daphne Owens
Journal:  World J Diabetes       Date:  2015-07-10

Review 2.  The Gastrointestinal Tract as Prime Site for Cardiometabolic Protection by Dietary Polyphenols.

Authors:  Jose A Villa-Rodriguez; Idolo Ifie; Gustavo A Gonzalez-Aguilar; Diana E Roopchand
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

3.  Small Heterodimer Partner and Fibroblast Growth Factor 19 Inhibit Expression of NPC1L1 in Mouse Intestine and Cholesterol Absorption.

Authors:  Young-Chae Kim; Sangwon Byun; Sunmi Seok; Grace Guo; H Eric Xu; Byron Kemper; Jongsook Kim Kemper
Journal:  Gastroenterology       Date:  2018-12-03       Impact factor: 22.682

4.  Mechanisms of Niemann-Pick type C1 Like 1 protein degradation in intestinal epithelial cells.

Authors:  Pooja Malhotra; Vinay Soni; Yoshihide Yamanashi; Tappei Takada; Hiroshi Suzuki; Ravinder K Gill; Seema Saksena; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Cell Physiol       Date:  2019-02-21       Impact factor: 4.249

5.  Impact of a high-cholesterol diet on expression levels of Niemann-Pick C1-like 1 and intestinal transporters in rats and mice.

Authors:  Atsushi Kawase; Yasuha Araki; Yukiko Ueda; Sayaka Nakazaki; Masahiro Iwaki
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2015-02-26       Impact factor: 2.441

6.  Role of SHP2 protein tyrosine phosphatase in SERT inhibition by enteropathogenic E. coli (EPEC).

Authors:  Megha Singhal; Christopher Manzella; Vinay Soni; Waddah A Alrefai; Seema Saksena; Gail A Hecht; Pradeep K Dudeja; Ravinder K Gill
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-16       Impact factor: 4.052

Review 7.  Intestinal lipid absorption and transport in type 2 diabetes.

Authors:  Bruno Vergès
Journal:  Diabetologia       Date:  2022-07-30       Impact factor: 10.460

8.  The N-reductive system composed of mitochondrial amidoxime reducing component (mARC), cytochrome b5 (CYB5B) and cytochrome b5 reductase (CYB5R) is regulated by fasting and high fat diet in mice.

Authors:  Heyka H Jakobs; Michal Mikula; Antje Havemeyer; Adriana Strzalkowska; Monika Borowa-Chmielak; Artur Dzwonek; Marta Gajewska; Ewa E Hennig; Jerzy Ostrowski; Bernd Clement
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

Review 9.  A Newly Integrated Model for Intestinal Cholesterol Absorption and Efflux Reappraises How Plant Sterol Intake Reduces Circulating Cholesterol Levels.

Authors:  Takanari Nakano; Ikuo Inoue; Takayuki Murakoshi
Journal:  Nutrients       Date:  2019-02-01       Impact factor: 5.717

10.  The intestinal microbiota regulates host cholesterol homeostasis.

Authors:  Tiphaine Le Roy; Emelyne Lécuyer; Benoit Chassaing; Moez Rhimi; Marie Lhomme; Samira Boudebbouze; Farid Ichou; Júlia Haro Barceló; Thierry Huby; Maryse Guerin; Philippe Giral; Emmanuelle Maguin; Nathalie Kapel; Philippe Gérard; Karine Clément; Philippe Lesnik
Journal:  BMC Biol       Date:  2019-11-27       Impact factor: 7.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.